GCIA
RVPHW

Gabelli & Co Investment Advisers’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio RVPHW Stock Details RVPHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-110,900
Closed -$75K – 440
2020
Q4 		$75K Sell
110,900
-32,700
-23% -$17.9K 0.01% 294
2020
Q3 		$73K Sell
143,600
-50,900
-26% -$22.7K 0.01% 218
2020
Q2 		$91K Hold
194,500
– – 0.02% 167
2020
Q1 		$18K Hold
194,500
– – ﹤0.01% 185
2019
Q4 		$49K Hold
194,500
– – 0.01% 186
2019
Q3 		$49K Hold
194,500
– – 0.01% 179
2019
Q2 		$41K Hold
194,500
– – ﹤0.01% 189
2019
Q1 		$31K Buy
+194,500
New +$38.5K ﹤0.01% 168

Other funds holding RVPHW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Gabelli & Co Investment Advisers's RVPHW Position: Q1 2021 in Review

Gabelli & Co Investment Advisers sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q1 2021, closing a stake of 110,900 shares — an estimated $75K sold.

Gabelli & Co Investment Advisers first reported a position in RVPHW in Q1 2019 and held it in 8 quarters. The position peaked at $91K in Q2 2020. 12 funds tracked by Wall St. Rank hold RVPHW as of Q1 2021.

  • Gabelli & Co Investment Advisers reported no remaining Reviva Pharmaceuticals Warrants position as of Q1 2021 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 110,900 Reviva Pharmaceuticals Warrants shares in Q1 2021, an estimated $75K.
  • Gabelli & Co Investment Advisers first reported a position in Reviva Pharmaceuticals Warrants in Q1 2019 and held it in 8 quarters.
  • Gabelli & Co Investment Advisers's Reviva Pharmaceuticals Warrants position peaked at $91K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q1 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2021, filed 14 May 2021.